Author:
Torrecilla Josune,del Pozo-Rodríguez Ana,Vicente-Pascual Mónica,Solinís María Ángeles,Rodríguez-Gascón Alicia
Funder
UPV/EHU
Spanish Ministry of Economy and Competitiveness
FEDER funds
University of the Basque Country UPV/EHU
Subject
Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology
Reference175 articles.
1. In situ injury-induced release of basic-fibroblast growth factor from corneal epithelial cells;Adamis;Am. J. Pathol.,1991
2. Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth;Albuquerque;Nat. Med.,2009
3. Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea;Afonso;Invest. Ophthalmol. Vis. Sci.,1999
4. Topical versus subconjunctival anti-vascular endothelial growt factor therapy (Bevacizumab, Ranibizumab and Aflibercept) for treatment of corneal neovascularization;Al-Debasi;Saudi J. Ophthalmol,2017
5. Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization;Amano;Invest. Ophthalmol. Vis. Sci.,1998
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献